Enlargement of Infarct Size by CKD Is Preventable by Consistent Activation of the Erythropoietin Receptor

Journal of Cardiac Failure - United States
doi 10.1016/j.cardfail.2015.08.201
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Proteasomes Regulate the Duration of Erythropoietin Receptor Activation by Controlling Down-Regulation of Cell Surface Receptors

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2000English

Reduction of Experimental Myocardial Infarct Size by Corticosteroid Administration

Journal of Clinical Investigation
Medicine
1973English

Sequential Activation of Splenic Nuclear RNA Polymerases by Erythropoietin.

Journal of Clinical Investigation
Medicine
1976English

The Significance of Erythropoietin Receptor (EpoR) Acquisition by Breast Cancer Cells

2006English

Size Enlargement of Pharmaceutical Powders by Wet Agglomeration and Drying Techniques

KONA Powder and Particle Journal
Materials ScienceEngineeringChemistryChemical Engineering
1993English

Psychological Tyranny Prescribed by the DWP: Preventable Harm Is Government Policy

British Journal of General Practice
MedicineFamily Practice
2018English

Enlargement of High Density Lipoprotein in Mice via Liver X Receptor Activation Requires Apolipoprotein E and Is Abolished by Cholesteryl Ester Transfer Protein Expression

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2003English

Experimental Evaluation of the Extent of Myocardial Dyssynergy and Infarct Size by Two-Dimensional Echocardiography

Circulation
Cardiovascular MedicinePhysiologyCardiology
1981English

Erythropoietin Receptor Signaling Is Membrane Raft Dependent

PLoS ONE
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy